Galenica AG Reports Consolidated Sales Results for the Year 2017; Provides Earnings Guidance for the Year 2017
January 18, 2018 at 12:50 pm
Share
Galenica AG reported consolidated sales results for the year 2017. For the year, the company reported net sales of CHF 3,214.2 million against CHF 3,008.9 million a year ago.
For the year, the company expects financial year 2017 announced in August with the half- year report 2017, i.e. growth in EBIT (excluding the effects of IAS 19) of between 7% and 12% compared with the previous year, including the one-off effects of CHF 7.0 million.
Galenica AG, previously Galenica Sante Ltd, is a Switzerland-based healthcare services and products provider. The Company's business i divided into three business sectors: Retail, Products & Brands, and Services. The Company manages a locally established pharmacies network in Switzerland. It develops and distributes its own product portfolio, as well as cooperates with a range of business partners, such as Pierre Fabre, Ales Groupe and Vitor Consumer Health for marketing and distribution of such brands as Perskindol, Triofan, A-Derma, Lierac, Phyto, Anti-Brumm and Algifor. Galenica Sante's Services business sector is responsible for management of such logistics sector companies as Galexis, Unione Farmaceutica Distribuzione, Alloga and Medifilm.